Dipna Pharmachem Key Ratios
BSE: 543594
₹5.31
₹-0.11
(-2.03%)
As on 28-Aug-2026IST
Market cap
₹14 Cr
Revenue (TTM)
₹125 Cr
P/E Ratio
5.3
P/B Ratio
0.3
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -87.12 | -23.99 | 19.74 | 32.54 |
| EBIT | -- | -64.50 | 12.00 | 20.14 | 54.73 |
| Net Profit | -- | -64.27 | -10.25 | -5.84 | 75.21 |
| EPS | -- | -67.32 | -10.26 | -80.78 | -32.47 |
| Book Value | -- | -- | 2.60 | -42.69 | -9.78 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | Mar-25 | Mar-24 | Mar-23 |
| EBIT-Margin
| 2.55 | 2.40 | 3.13 | 2.12 | 2.39 |
| Net Margin
| 0.78 | 0.81 | 0.78 | 0.66 | 0.91 |
| Return on equity
| 4.35 | 23.68 | 2.56 | 3.51 | 6.99 |
| Return on Capital
| 7.77 | 9.00 | 6.95 | 7.18 | 9.17 |
| Return on Assets
| 1.12 | 1.46 | 0.73 | 1.03 | 1.60 |
| Debt to Equity (x)
| -- | -- | 0.45 | 0.52 | 0.65 |
Profitability
ROCE
6.95
Lower than Peers by 7.76
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Dipna Pharmachem
|
6.95
|
7.18
|
9.17
|
18.16
|
3.54
|
|
Peer Median
|
14.72
|
18.85
|
11.60
|
11.89
|
--
|
ROE
2.56
Lower than Peers by 9.11
Profit after tax / Average Net worth * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Dipna Pharmachem
|
2.56
|
3.51
|
6.99
|
101.02
|
4.32
|
|
Peer Median
|
11.67
|
14.92
|
11.46
|
13.43
|
--
|
ROA
0.73
Lower than Peers by 7.12
Profit after tax / Average Total assets * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Dipna Pharmachem
|
0.73
|
1.03
|
1.60
|
3.82
|
0.11
|
|
Peer Median
|
7.86
|
9.06
|
6.44
|
7.03
|
--
|
EBIT Margin
3.13
Lower than Peers by 11.90
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Dipna Pharmachem
|
3.13
|
2.12
|
2.39
|
3.10
|
1.27
|
|
Peer Median
|
15.03
|
14.71
|
12.37
|
16.50
|
--
|
Net Margin
0.78
Lower than Peers by 8.55
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Dipna Pharmachem
|
0.78
|
0.66
|
0.91
|
1.60
|
0.08
|
|
Peer Median
|
9.33
|
8.49
|
10.02
|
10.49
|
--
|
Cash Profit Margin
0.79
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Dipna Pharmachem
|
0.79
|
0.67
|
0.92
|
1.61
|
0.10
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
-23.99
Lower than Peers by 34.26
Year on year growth in net sales
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Dipna Pharmachem
|
-23.99
|
64.46
|
37.35
|
134.70
|
1.51
|
|
Peer Median
|
10.27
|
11.85
|
9.08
|
13.45
|
--
|
EBIT Growth
12.00
Lower than Peers by 12.15
Year on year growth in operating profit (EBIT)
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Dipna Pharmachem
|
12.00
|
46.09
|
5.98
|
471.38
|
-10.47
|
|
Peer Median
|
24.15
|
28.00
|
-3.12
|
18.27
|
--
|
Net Profit Growth
-10.25
Lower than Peers by 40.54
Year on year growth in profit after tax
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Dipna Pharmachem
|
-10.25
|
19.02
|
-21.85
|
4,721.77
|
-58.98
|
|
Peer Median
|
30.29
|
36.51
|
-0.85
|
27.20
|
--
|
EPS Growth
-10.26
Lower than Peers by 34.76
Year on year growth in earnings per share
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Dipna Pharmachem
|
-10.26
|
-27.88
|
-98.90
|
4,721.77
|
-58.98
|
|
Peer Median
|
24.50
|
--
|
-6.82
|
16.28
|
--
|
Book Value Growth
2.60
--
Year on year growth in book value per share
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Dipna Pharmachem
|
2.60
|
54.03
|
1,301.06
|
204.10
|
4.42
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
0.45
Higher than Peers by 0.22
Total debt / Net worth
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Dipna Pharmachem
|
0.45
|
0.52
|
0.65
|
5.86
|
21.74
|
|
Peer Median
|
0.23
|
0.20
|
0.15
|
0.15
|
--
|
Short term debt to equity ratio
0.22
--
(Short term borrowings / Net worth)
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Dipna Pharmachem
|
0.22
|
0.18
|
0.20
|
2.53
|
15.29
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
1.56
Lower than Peers by 0.24
Current Assets / Current Liabilities and Provisions
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Dipna Pharmachem
|
1.56
|
1.60
|
1.84
|
1.26
|
1.21
|
|
Peer Median
|
1.79
|
1.96
|
2.08
|
1.89
|
--
|
Quick Ratio
1.23
Lower than Peers by 0.23
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Dipna Pharmachem
|
1.23
|
1.15
|
1.39
|
1.04
|
0.85
|
|
Peer Median
|
1.47
|
1.44
|
1.58
|
1.64
|
--
|
Interest Coverage
1.57
Lower than Peers by 7.85
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Dipna Pharmachem
|
1.57
|
1.69
|
2.36
|
3.29
|
1.16
|
|
Peer Median
|
9.42
|
8.58
|
15.41
|
15.38
|
--
|
Operating Efficiency
Debtors to sales
37.05
Higher than Peers by 11.23
Debtors outstanding / Net Sales * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Dipna Pharmachem
|
37.05
|
18.83
|
28.55
|
37.08
|
48.22
|
|
Peer Median
|
25.82
|
26.12
|
22.96
|
20.72
|
--
|
Asset Turnover
0.94
Higher than Peers by 0.19
Sales / Average Total Assets
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Dipna Pharmachem
|
0.94
|
1.56
|
1.76
|
2.38
|
1.43
|
|
Peer Median
|
0.75
|
0.77
|
0.65
|
0.61
|
--
|
Receivable days
112.80
--
Average Debtors / Sales * 365
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Dipna Pharmachem
|
112.80
|
66.04
|
101.37
|
105.16
|
153.94
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
94.70
--
Average Inventory / Sales * 365
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Dipna Pharmachem
|
94.70
|
62.55
|
46.11
|
33.86
|
75.05
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
241.13
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Dipna Pharmachem
|
241.13
|
128.07
|
113.36
|
92.66
|
123.97
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
-33.63
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Dipna Pharmachem
|
-33.63
|
0.52
|
34.12
|
46.36
|
105.02
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
35.30
Lower than Peers by 4.40
Current share price divided by earning per share in the last twelve months
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Dipna Pharmachem
|
35.30
|
20.87
|
13.54
|
--
|
--
|
|
Peer Median
|
39.70
|
33.48
|
37.74
|
60.11
|
--
|
Price / Book Value
0.89
Lower than Peers by 2.83
Current share price divided by book value per share in the latest financial year
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Dipna Pharmachem
|
0.89
|
0.60
|
0.62
|
--
|
--
|
|
Peer Median
|
3.72
|
4.21
|
3.22
|
3.92
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Dipna Pharmachem
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.16
|
0.21
|
0.57
|
0.56
|
--
|
EV/EBITDA
13.02
Lower than Peers by 17.20
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Dipna Pharmachem
|
13.02
|
8.04
|
10.49
|
4.41
|
29.28
|
|
Peer Median
|
30.23
|
29.90
|
28.81
|
25.94
|
--
|
Market Cap
34
Lower than Peers by 4,816
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Dipna Pharmachem
|
34
|
23
|
15
|
--
|
--
|
|
Peer Median
|
4,851
|
2,099
|
15,272
|
13,501
|
--
|
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
